Dr. Alex Dobranowski of Healwell reports

WELL HEALTH FOUNDER & CEO HAMED SHAHBAZI APPOINTED CHAIRMAN OF THE BOARD OF HEALWELL AI

Healwell AI Inc. has appointed Hamed Shahbazi as chairman of the board of Healwell. Mr. Shahbazi is currently the chairman and chief executive officer of Well Health Technologies Corp., Canada's largest owner-operator of outpatient medical clinics and leading digital health service providing software and services to more than one-third of all Canadian physicians. Mr. Shahbazi has served on the board of Healwell since its launch on Oct. 1, 2023. Mr. Shahbazi's appointment to chairman of Healwell is strategically important for shareholders of both Well and Healwell given Well's equity ownership of Healwell, its option to become a controlling shareholder based on an option to acquire multivoting shares (see details herein) and the shared objective between the companies to leverage AI (artificial intelligence) and other leading-edge technologies to support health care providers.

Mr. Shahbazi, founder and chief executive officer of Well, commented on his appointment: "As a co-founder of Healwell, I am personally very proud and excited to take on the role of chairman for Healwell AI given the enormous importance of the shared mission and objective we have between Well and Healwell. Well exists to tech enable health care providers and there isn't a more important objective in our company and industry right now than to support our health care providers given the enormous burdens they currently face without adequate tools or assistance. Our objective, together with Healwell, is to create the most advanced and easy-to-use AI-inspired tools that can equip providers with various co-pilots that can help diagnose rare and chronic diseases, improve efficiency of their practice, and help improve patient health outcomes."

Mr. Shahbazi continued, "Well has already invested significantly in Healwell and we will continue to invest more time, resources and support for the long-term to ensure that Healwell is a world-class company and leader in delivering AI-powered preventative care to millions of patients."

Mr. Shahbazi is the founder, chief executive officer and chairman of Well and has over 25 years of experience as a technology-focused operator and executive. Over the past six years, Mr. Shahbazi has led Well to become the leading digital health care company in Canada, profitably approaching $1-billion in annual revenue and having a significant positive impact on the industry. Previously, he founded TIO Networks, a multichannel payment solution provider, specializing in bill payment and other financial services, which was acquired by PayPal in July, 2017. Over his career, Mr. Shahbazi has gained extensive experience in strategic mergers and acquisitions, both as an operator and board member with more than 80 successful transactions worth more than $2-billion.

Concurrent to Mr. Shahbazi's appointment, Kingsley Ward will be stepping down from Healwell's chairman position but will continue to serve as an independent director on Healwell's board.

Dr. Alexander Dobranowski, co-founder and chief executive officer of Healwell, commented: "I would like to extend my sincerest thanks to Kingsley for his contributions and invaluable leadership as chairman, especially through the months preceding the debut of Healwell. As we continue this exciting journey of building a leading health care artificial intelligence company, we are excited to welcome Hamed into the role as chairman. Hamed's experience as one of the most significant capital allocators in the Canadian corporate landscape and his growing success in building one of the most important health care companies in Canada make him exceptionally well suited for this role."

On Oct. 1, 2023, Healwell announced a strategic alliance agreement with Well to accelerate the growth and development of its AI-enabled health care technologies and to leverage those technologies for the benefit of the care providers in Well's expansive network, which not only includes Well's own network of outpatient clinics, which ranks as the largest in the country but also its provider-centric digital platform that touches more than a third of all care providers in Canada. Subsequent to this announcement, Well launched its own clinical decision support product branded as Well AI Decision Support. This product leverages AI technologies to help providers enable the earlier diagnosis, treatment and improved quality of life for patients. The technologies behind Well AI Decision Support are exclusively developed and supplied by Healwell and have been meticulously developed in close collaboration with dedicated physicians, leading researchers, data privacy professionals, pharmaceutical companies and other domain experts.

Well is currently the largest shareholder of Healwell with an option that would give Well a control position in Healwell, as defined on an IFRS (international financial reporting standards) financial reporting basis. Well currently holds 22.7 million shares of Healwell, thereby representing 20.7 per cent of the issued and outstanding voting securities of Healwell. Well's call option gives Well the right to acquire up to an additional approximately 30 million Class A subordinate voting shares and the same number of Class B multiple voting shares of the company. The call option is available to Well on Oct. 1, 2025, and is exercisable until Oct. 1, 2026, unless Healwell meets specific performance milestones designed to demonstrate improvements in financial performance, in which case Well may exercise its option earlier.

About Well Health Technologies Corp.

Well's mission is to tech enable health care providers. The company does this by developing the best technologies, services and support available, which ensures health care providers are empowered to positively impact patient outcomes. Well's comprehensive health care and digital platform includes extensive front-office and back-office management software applications that help physicians run and secure their practices. Well's solutions enable more than 33,000 health care providers between the United States and Canada and power the largest owned and operated health care ecosystem in Canada with more than 150 clinics supporting primary care, specialized care and diagnostic services. In the United States, Well's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, mental health, revenue cycle management and practitioner recruiting. Well is publicly traded on the Toronto Stock Exchange under the symbol WELL and on the OTC Exchange under the symbol WHTCF.

About Healwell AI Inc.

Healwell is a health care technology company focused on AI and data science for preventative care. Its mission is to improve health care and save lives through early identification and detection of disease. Using its own proprietary technology, the company is developing and commercializing advanced clinical decision support systems that can help health care providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. Healwell is executing a strategy centred around developing and acquiring technology and clinical sciences capabilities that complement the company's road map. Healwell is publicly traded on the TSX under the symbol AIDX and on the OTC Exchange under the symbol HWAIF.

We seek Safe Harbor.